Compile Data Set for Download or QSAR
Report error Found 68 Enz. Inhib. hit(s) with all data for entry = 9695
TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482186BDBM482186(US10918642, Cmpd # 27 | 2,3-Dihydro-benzofuran-5-s...)
Affinity DataIC50: 16nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482217BDBM482217(US10918642, Cmpd # 71 | N-{3-[4-Amino-7-(1-methyl-...)
Affinity DataIC50: 16nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482183BDBM482183(US10918642, Cmpd # 24 | N-[3-(4-Amino-7-methyl-7H-...)
Affinity DataIC50: 16nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482207BDBM482207(US10918642, Cmpd # 52 | N-[3-(4-Amino-7-methyl-7H-...)
Affinity DataIC50: 16nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482171BDBM482171(US10918642, Cmpd # 13 | N-[3-(4-Amino-7-methyl-7H-...)
Affinity DataIC50: 16nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482167BDBM482167(US10918642, Cmpd # 9 | N-[3-(4-Amino-1-methyl-1H-p...)
Affinity DataIC50: 16nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482201BDBM482201(US10918642, Cmpd # 46 | N-[3-(4-Amino-7-methyl-7H-...)
Affinity DataIC50: 16nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482166BDBM482166(US10918642, Cmpd # 6 | N-{3-[4-Amino-7-(1-isopropy...)
Affinity DataIC50: 16nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482200BDBM482200(US10918642, Cmpd # 44 | N-[3-(4-Amino-7-methyl-7H-...)
Affinity DataIC50: 16nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482164BDBM482164(US10918642, Cmpd # 4 | N-{3-[4-Amino-7-(1-methyl-p...)
Affinity DataIC50: 16nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482163BDBM482163(US10918642, Cmpd # 3 | N-[3-(4-Amino-7-(1-methyl-p...)
Affinity DataIC50: 16nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482162BDBM482162(US10918642, Cmpd # 2 | N-[3-(4-Amino-7-isopropyl-7...)
Affinity DataIC50: 16nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482196BDBM482196(US10918642, Cmpd # 38 | N-{3-[4-Amino-7-(1-methyl-...)
Affinity DataIC50: 16nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482228BDBM482228(US10918642, Cmpd # 87 | N-[3-(4-Amino-7-methyl-7H-...)
Affinity DataIC50: 16nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482193BDBM482193(US10918642, Cmpd # 35 | N-[3-(4-Amino-1-methyl-1H-...)
Affinity DataIC50: 16nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482219BDBM482219(US10918642, Cmpd # 73 | N-{3-[4-Amino-7-(1-methyl-...)
Affinity DataIC50: 16nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482218BDBM482218(US10918642, Cmpd # 72 | N-{3-[4-Amino-7-(1-methyl-...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482213BDBM482213(US10918642, Cmpd # 64 | N-[3-(4-Amino-7-piperidin-...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482212BDBM482212(US10918642, Cmpd # 63 | N-[3-(4-Amino-1-piperidin-...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482211BDBM482211(US10918642, Cmpd # 62 | N-[3-(4-Amino-1-piperidin-...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482210BDBM482210(US10918642, Cmpd # 61 | N-{3-[4-Amino-1-(1-methyl-...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482206BDBM482206(US10918642, Cmpd # 51 | N-[3-(4-Amino-7-methyl-7H-...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482203BDBM482203(US10918642, Cmpd # 48 | 5-Bromo-thiophene-2-sulfon...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482165BDBM482165(US10918642, Cmpd # 5 | N-{3-[4-Amino-7-(1-cyclopro...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482161BDBM482161(US10918642, Cmpd # 1 | N-[3-(4-Amino-7-methyl-7H-p...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482227BDBM482227(US10918642, Cmpd # 86 | N-[3-(4-Amino-7-methyl-7H-...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482226BDBM482226(US10918642, Cmpd # 85 | N-[3-(4-Amino-7-methyl-7H-...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482224BDBM482224(US10918642, Cmpd # 79 | N-[3-(4-Amino-7-methyl-7H-...)
Affinity DataIC50: 33nMAssay Description:Serially diluted compounds were incubated for 60 minutes at room temperature in the presence of ATP/P33 gammaATP mix, substrate and enzyme in a volum...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482223BDBM482223(US10918642, Cmpd # 77 | 5-Bromo-thiophene-2-sulfon...)
Affinity DataIC50: 33nMAssay Description:Serially diluted compounds were incubated for 60 minutes at room temperature in the presence of ATP/P33 gammaATP mix, substrate and enzyme in a volum...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482221BDBM482221(US10918642, Cmpd # 75 | N-[3-(4-Amino-7-ethyl-7H-p...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482185BDBM482185(US10918642, Cmpd # 26 | N-[2-(4-Amino-7-methyl-7H-...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482184BDBM482184(US10918642, Cmpd # 25 | N-[3-(4-Amino-7-methyl-7H-...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482181BDBM482181(US10918642, Cmpd # 22 | N-[3-(4-Amino-7-methyl-7H-...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482177BDBM482177(US10918642, Cmpd # 19 | N-[3-(4-Amino-7-methyl-7H-...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482170BDBM482170(US10918642, Cmpd # 12 | N-[3-(4-Amino-7-methyl-7H-...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482202BDBM482202(US10918642, Cmpd # 47 | 5-Chloro-thiophene-2-sulfo...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482199BDBM482199(US10918642, Cmpd # 41 | N-{3-[4-Amino-7-(1-ethyl-p...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482198BDBM482198(US10918642, Cmpd # 40 | N-{3-[4-Amino-7-(1-isoprop...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482197BDBM482197(US10918642, Cmpd # 39 | N-{3-[4-Amino-7-(1-cyclopr...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482195BDBM482195(US10918642, Cmpd # 37 | N-{3-[4-Amino-7-(tetrahydr...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482194BDBM482194(US10918642, Cmpd # 36 | N-{3-[4-Amino-7-(tetrahydr...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482192BDBM482192(US10918642, Cmpd # 34 | N-[3-(4-Amino-1-methyl-1H-...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482191BDBM482191(US10918642, Cmpd # 33 | 5-Bromo-6-chloro-pyridine-...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482190BDBM482190(US10918642, Cmpd # 32 | N-[3-(4-Amino-7-methyl-7H-...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482188BDBM482188(US10918642, Cmpd # 29 | N-[3-(4-Amino-7-methyl-7H-...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482187BDBM482187(US10918642, Cmpd # 28 | N-[3-(4-Amino-7-methyl-7H-...)
Affinity DataIC50: 33nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482215BDBM482215(US10918642, Cmpd # 66 | N-{3-[4-Amino-1-(1-methyl-...)
Affinity DataIC50: 105nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482182BDBM482182(US10918642, Cmpd # 23 | N-[3-(4-Amino-7-methyl-7H-...)
Affinity DataIC50: 105nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482214BDBM482214(US10918642, Cmpd # 65 | N-{3-[4-Amino-1-(1-isoprop...)
Affinity DataIC50: 105nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Nerviano Medical Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 482176BDBM482176(US10918642, Cmpd # 18 | 4-Methyl-3,4-dihydro-2H-be...)
Affinity DataIC50: 105nMAssay Description:Compounds were 3-fold serially diluted in order to obtain from 3.333 to 0.000169 microM final concentration, then incubated for 60 minutes at room te...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2021
Entry Details
US Patent

Displayed 1 to 50 (of 68 total ) | Next | Last >>
Jump to: